New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Whole-genome sequencing used to track down genes behind familial glioma

Whole-genome sequencing used to track down genes behind familial glioma

by Bob Yirka , Medical XpressProportion of the glioma exploratory cohort (green) or control cohort (blue) with variants in seven cancer genes and overall. P values were calculated with Fisher’s exact
World medicine December 13,2023
Whole-genome sequencing used to track down genes behind familial glioma

Whole-genome sequencing used to track down genes behind familial glioma

by Bob Yirka , Medical XpressProportion of the glioma exploratory cohort (green) or control cohort (blue) with variants in seven cancer genes and overall. P values were calculated with Fisher’s exact
World medicine December 13,2023
Leukemia and head and neck cancer drugs not approved for NHS England

Leukemia and head and neck cancer drugs not approved for NHS England

byCancer Research UKCredit: CC0 Public DomainPeople with head and neck cancer or leukemia in England are set to miss out on access to two new cancer drugs, after the National Institute for Healt
World medicine December 13,2023
Leukemia and head and neck cancer drugs not approved for NHS England

Leukemia and head and neck cancer drugs not approved for NHS England

byCancer Research UKCredit: CC0 Public DomainPeople with head and neck cancer or leukemia in England are set to miss out on access to two new cancer drugs, after the National Institute for Healt
World medicine December 13,2023
Weight gain in late teens and 20s associated with higher risk of fatal prostate cancer

Weight gain in late teens and 20s associated with higher risk of fatal prostate cancer

by European Association for the Study of ObesityCredit: Pixabay/CC0 Public DomainWeight gain in a man's late teens and 20s increases his risk of dying from prostate cancer later in life, research
World medicine December 13,2023
Weight gain in late teens and 20s associated with higher risk of fatal prostate cancer

Weight gain in late teens and 20s associated with higher risk of fatal prostate cancer

by European Association for the Study of ObesityCredit: Pixabay/CC0 Public DomainWeight gain in a man's late teens and 20s increases his risk of dying from prostate cancer later in life, research
World medicine December 13,2023
Further improvements in survival seen after allogeneic transplant

Further improvements in survival seen after allogeneic transplant

(HealthDay)—From 2003-2007 to 2013-2017, there was an improvement in survival for allogeneic hematopoietic cell transplantation, according to a study published online Jan. 21 in theAnnals of Int
World medicine December 13,2023
Further improvements in survival seen after allogeneic transplant

Further improvements in survival seen after allogeneic transplant

(HealthDay)—From 2003-2007 to 2013-2017, there was an improvement in survival for allogeneic hematopoietic cell transplantation, according to a study published online Jan. 21 in theAnnals of Int
World medicine December 13,2023
Massachusetts health reform tied to decrease in advanced cancer

Massachusetts health reform tied to decrease in advanced cancer

(HealthDay)—Following state health reform, there was a decline in advanced-stage colorectal cancer (CRC) diagnoses in Massachusetts, according to a study published in the February issue ofMedica
World medicine December 13,2023
Massachusetts health reform tied to decrease in advanced cancer

Massachusetts health reform tied to decrease in advanced cancer

(HealthDay)—Following state health reform, there was a decline in advanced-stage colorectal cancer (CRC) diagnoses in Massachusetts, according to a study published in the February issue ofMedica
World medicine December 13,2023
Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?

Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?

by Impact Journals LLCThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D
World medicine December 13,2023
Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?

Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?

by Impact Journals LLCThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D
World medicine December 13,2023
PET/MRI identifies notable breast cancer imaging biomarkers

PET/MRI identifies notable breast cancer imaging biomarkers

by Society of Nuclear Medicine and Molecular ImagingA 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT
World medicine December 13,2023
PET/MRI identifies notable breast cancer imaging biomarkers

PET/MRI identifies notable breast cancer imaging biomarkers

by Society of Nuclear Medicine and Molecular ImagingA 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT
World medicine December 13,2023
Robust analysis challenges theory that depression and anxiety increase cancer risk

Robust analysis challenges theory that depression and anxiety increase cancer risk

byWileyCredit: Unsplash/CC0 Public DomainDepression and anxiety are thought to increase a person's risk of developing cancer, but research results have been inconclusive. In an analysis of m
World medicine December 13,2023
Robust analysis challenges theory that depression and anxiety increase cancer risk

Robust analysis challenges theory that depression and anxiety increase cancer risk

byWileyCredit: Unsplash/CC0 Public DomainDepression and anxiety are thought to increase a person's risk of developing cancer, but research results have been inconclusive. In an analysis of m
World medicine December 13,2023
Antiviral treatments inspire researchers to develop a new kind of cancer drug

Antiviral treatments inspire researchers to develop a new kind of cancer drug

byStanford UniversityJeffrey S. Glenn, M.D., Ph.D. Credit: Jeffrey S. Glenn, M.D., Ph.D.Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked
World medicine December 13,2023
Antiviral treatments inspire researchers to develop a new kind of cancer drug

Antiviral treatments inspire researchers to develop a new kind of cancer drug

byStanford UniversityJeffrey S. Glenn, M.D., Ph.D. Credit: Jeffrey S. Glenn, M.D., Ph.D.Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked
World medicine December 13,2023
Personalized dosing in prostate cancer treatment found to improve patient outcomes

Personalized dosing in prostate cancer treatment found to improve patient outcomes

by Society of Nuclear Medicine and Molecular ImagingOutcomes from response groups based on PSA and Lu SPECT at six weeks. Credit: A. Nguyen et al., St. Vincent's Hospital SydneyBy monitoring early
World medicine December 13,2023
Personalized dosing in prostate cancer treatment found to improve patient outcomes

Personalized dosing in prostate cancer treatment found to improve patient outcomes

by Society of Nuclear Medicine and Molecular ImagingOutcomes from response groups based on PSA and Lu SPECT at six weeks. Credit: A. Nguyen et al., St. Vincent's Hospital SydneyBy monitoring early
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com